ANDA 77032, held by Sun Pharm Inds Inc. Citalopram Hydrobromide.
As of Nov 15, 2026, ANDA 77032 (Citalopram Hydrobromide), held by Sun Pharm Inds Inc, was first approved by FDA on Nov 12, 2004, with 14 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 12, 2004 | Original application | Approved | None posted |
| Citalopram HydrobromideEQ 10MG BASE · tablet;oral | Citalopram Hydrobromide | Discontinued |
| Citalopram HydrobromideEQ 20MG BASE · tablet;oral | Citalopram Hydrobromide | Discontinued |
| Citalopram HydrobromideEQ 40MG BASE · tablet;oral | Citalopram Hydrobromide | Discontinued |
| Nov 26, 2024 | Supplement 25Labeling · Standard review | Approved | None posted |
| Nov 26, 2024 | Supplement 26Labeling · Standard review | Approved | None posted |
| Nov 26, 2024 | Supplement 28Labeling · Standard review | Approved | None posted |
| Dec 27, 2012 | Supplement 17Labeling | Approved | None posted |
| Dec 27, 2012 | Supplement 21Labeling · Standard review | Approved | None posted |
| Aug 4, 2010 | Supplement 15Manufacturing | Approved | None posted |
| Mar 6, 2009 | Supplement 14Labeling | Approved | None posted |
| Feb 19, 2009 | Supplement 13Labeling | Approved | None posted |
| Oct 25, 2007 | Supplement 11Labeling | Approved | None posted |
| Jun 28, 2007 | Supplement 10Labeling | Approved | None posted |
| Sep 13, 2006 | Supplement 7Labeling | Approved | None posted |
| Feb 14, 2006 | Supplement 6Labeling | Approved | None posted |
| May 27, 2005 | Supplement 3Labeling | Approved | None posted |
| May 11, 2005 | Supplement 2Labeling | Approved | None posted |
| Nov 12, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
